World's Best Scientists 2026 revealed!

Robert S. Coffin publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Robert S. Coffin sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

The last bar groups every scientist with 679 publications or more.

Robert S. Coffin D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert S. Coffin sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

The last bar groups every scientist with 127 D-Index or more.

Overview

Robert S. Coffin is affiliated with University College London in the United Kingdom. Their research encompasses multiple domains within biomedical science, particularly focusing on the interface of virology, immunology, and oncology.

Their recent publications highlight work on oncolytic herpes simplex virus therapies combined with immune checkpoint inhibitors, reflecting a focus on cancer immunotherapy. Notable papers include:

  • Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer, 2020, Journal for ImmunoTherapy of Cancer
  • An open-label, single-arm, phase II clinical trial of RP1, an enhanced potency oncolytic herpes virus, combined with nivolumab in four solid tumor types: Initial results from the skin cancer cohorts, 2020, Journal of Clinical Oncology
  • Updated results from the skin cancer cohorts from an ongoing phase 1/2 multicohort study of RP1, an enhanced potency oncolytic HSV, combined with nivolumab (IGNYTE), 2022, Journal of Clinical Oncology
  • RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE), 2025, Journal of Clinical Oncology
  • Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease, 2024, Journal for ImmunoTherapy of Cancer

Coffin frequently collaborates with researchers including Praveen K. Bommareddy, Kevin J. Harrington, Joseph J. Sacco, Mark R. Middleton, and Anna Olsson-Brown. These co-authorships indicate active engagement in clinical and translational immunotherapy studies.

Their works are often published in venues such as:

  • Regular and Young Investigator Award Abstracts
  • Journal of Clinical Oncology
  • Cancer Research
  • Journal for ImmunoTherapy of Cancer

The main fields of study contributing to Coffin's research are:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine
  • Immunology and Microbiology

Within these broader domains, Coffin's subfields of study include:

  • Oncology
  • Genetics
  • Immunology
  • Biotechnology
  • Epidemiology

The principal topics covered by their research involve:

  • Virus-based gene therapy research
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Cancer Research and Treatments
  • Cancer Immunotherapy and Biomarkers
  • Herpesvirus Infections and Treatments
  • Interferon and immune responses

Best Publications

  • ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties.

    Liu Bl;Robinson M;Han Zq;Branston Rh

  • A Phase I Study of OncoVEXGM-CSF, a Second-Generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor

    Jennifer C.C. Hu;Robert S. Coffin;Ceri J. Davis;Nicola J. Graham

  • Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck.

    Kevin J. Harrington;Mohan Hingorani;Mary Anne Tanay;Jennifer Hickey

  • Protection of Neuronal Cells from Apoptosis by Hsp27 Delivered with a Herpes Simplex Virus-based Vector

    Marcus J.D. Wagstaff;Yollanda Collaço-Moraes;Yollanda Collaço-Moraes;Jill Smith;Jaqueline S. de Belleroche

  • The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review.

    D. Hunt;R.S. Coffin;P.N. Anderson

  • Development and Optimization of Herpes Simplex Virus Vectors for Multiple Long-Term Gene Delivery to the Peripheral Nervous System

    J. A. Palmer;R. H. Branston;C. E. Lilley;M. J. Robinson

  • Heat shock proteins delivered with a virus vector can protect cardiac cells against apoptosis as well as against thermal or hypoxic stress.

    B.K. Brar;A. Stephanou;M.J.D. Wagstaff;R.S. Coffin

  • Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.

    Caroline E. Lilley;Filitsa Groutsi;ZiQun Han;James A. Palmer

  • Deletion of the virion host shutoff protein (vhs) from herpes simplex virus (HSV) relieves the viral block to dendritic cell activation: potential of vhs- HSV vectors for dendritic cell-mediated immunotherapy.

    Laila Samady;Emanuela Costigliola;Luci MacCormac;Yvonne McGrath

  • Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury.

    Kazuya Kitamura;Akio Iwanami;Masaya Nakamura;Junichi Yamane

  • Bcl-2 Transcription from the Proximal P2 Promoter Is Activated in Neuronal Cells by the Brn-3a POU Family Transcription Factor

    Martin D. Smith;Elizabeth A. Ensor;Robert S. Coffin;Linda M. Boxer

  • Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector.

    Ming Zhu Zhao;Naosuke Nonoguchi;Naokado Ikeda;Takuji Watanabe

  • Nogo Receptor mRNA Expression in Intact and Regenerating CNS Neurons

    David Hunt;M.R.J. Mason;G. Campbell;R. Coffin

  • Herpes Simplex Virus Infection of Dendritic Cells: Balance among Activation, Inhibition, and Immunity

    Gabriele Pollara;Katharina Speidel;Laila Samady;Mansi Rajpopat

  • Bone marrow stromal cells that enhanced fibroblast growth factor-2 secretion by herpes simplex virus vector improve neurological outcome after transient focal cerebral ischemia in rats

    Naokado Ikeda;Naosuke Nonoguchi;Ming Zhu Zhao;Takuji Watanabe

  • White paper on microbial anti-cancer therapy and prevention.

    Neil S. Forbes;Robert S. Coffin;Liang Deng;Laura Evgin

  • Nogo-A expression in the intact and injured nervous system.

    David Hunt;R.S Coffin;R.K Prinjha;G Campbell

  • In vivo myocardial gene transfer: optimization, evaluation and direct comparison of gene transfer vectors.

    M J Wright;L M L Wightman;C Lilley;M de Alwis

  • Infection of mature dendritic cells with herpes simplex virus type 1 dramatically reduces lymphoid chemokine-mediated migration

    Alexander T. Prechtel;Nadine M. Turza;Dieter J. Kobelt;Jutta I. Eisemann

  • Herpes simplex virus type-1-induced activation of myeloid dendritic cells: the roles of virus cell interaction and paracrine type I IFN secretion.

    Gabriele Pollara;Meleri Jones;Matthew E. Handley;Mansi Rajpopat

Frequent Co-Authors

Benjamin M. Chain
Benjamin M. Chain University College London
David R. Katz
David R. Katz University College London
Alexander Steinkasserer
Alexander Steinkasserer University of Erlangen-Nuremberg
Richard G. Vile
Richard G. Vile Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology in the USA opens doors to diverse career pathways, many of which can be further enhanced through related online programs. For those interested in integrating healthcare administration with their scientific knowledge, exploring the medical billing and coding certificate online accelerated can provide a competitive edge in healthcare settings and streamline career transitions.

Additionally, students aiming to broaden their expertise might consider various online medical programs. These can be a flexible way to gain complementary skills relevant to microbiology, such as public health or healthcare management, without having to relocate or attend traditional classes.

For those passionate about impacting community health, enrolling in some of the best easiest mph online programs to get into offers a practical route to gain public health credentials, supporting career growth in epidemiology and disease control.

Finally, combining a microbiology background with certifications to become a child life specialist can lead to meaningful work with young patients. Understanding roles and expectations, as well as the child life specialist salary, helps students weigh this rewarding career path in healthcare.

Best Scientists Citing Robert S. Coffin

Trending Scientists

Recently Published Articles